Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas-Reference-Cited by-同舟云学术

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas

Published:2019-01-25 Issue:7 Volume:33 Page:1687-1699
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Kataoka Keisuke^ORCID,Miyoshi Hiroaki,Sakata Seiji,Dobashi Akito,Couronné Lucile,Kogure Yasunori^ORCID,Sato Yasuharu,Nishida Kenji,Gion Yuka,Shiraishi Yuichi,Tanaka Hiroko,Chiba Kenichi,Watatani Yosaku,Kakiuchi Nobuyuki,Shiozawa Yusuke,Yoshizato Tetsuichi^ORCID,Yoshida Kenichi,Makishima Hideki^ORCID,Sanada Masashi,Onozawa Masahiro,Teshima Takanori^ORCID,Yoshiki Yumiko,Ishida Tadao,Suzuki Kenshi,Shimada Kazuyuki,Tomita Akihiro,Kato Motohiro^ORCID,Ota Yasunori,Izutsu Koji,Demachi-Okamura Ayako,Akatsuka Yoshiki,Miyano Satoru,Yoshino Tadashi,Gaulard Philippe,Hermine Olivier,Takeuchi Kengo^ORCID,Ohshima Koichi,Ogawa Seishi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0380-5.pdf

Reference38 articles.

1. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757–68.

2. Grywalska E, Markowicz J, Grabarczyk P, Pasiarski M, Rolinski J. Epstein-Barr virus-associated lymphoproliferative disorders. Post Hig Med Dosw. 2013;67:481–90.

3. Topalian SL, Taube JM, Anders RA, Pardoll DM. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer. 2016;16:275–87.

4. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348:56–61.

5. Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27:450–61.

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus;Clinical Microbiology Reviews;2024-09-12

2. Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma;Cancer Research;2024-04-24

3. Expression and prognostic significance of the PD‐1/PD‐L1 pathway in AIDS‐related non‐Hodgkin lymphoma;Cancer Medicine;2024-04

4. Understanding the Role of EBV Infection in Lymphomagenesis;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

5. Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma;Leukemia;2024-02-20